Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Plant

Showing results (321-330 of 339) with videos related to

Pageof 34
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 1, 2018
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV<sub>1</sub>) in cystic fibrosis patients receiving ivacaftor treatmentBéla Nagy, Zsolt Bene, Zsolt Fejes, et al.
Scientific Reports|November 6, 2025
Ultralow dose computed tomography as an alternative to conventional chest radiography for the evaluation of disease severity in paediatric cystic fibrosisMichael G Waldron, Patrick W O'Regan, Michael Lane, et al.
World Journal of Radiology|September 3, 2025
Ultra-low dose computed tomography chest <i>vs</i> chest radiography in paediatric primary ciliary dyskinesia: A prospective studyMichael G Waldron, Patrick W O'Regan, Michael Lane, et al.
The Journal of Infection|January 14, 2021
A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and levelJennifer Deane, Fiona Fouhy, Nicola J Ronan, et al.
Scientific Reports|July 29, 2017
A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic FibrosisF Fouhy, N J Ronan, O O'Sullivan, et al.
Chest|October 18, 2017
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With IvacaftorNicola J Ronan, Gisli G Einarsson, Maria Twomey, et al.
Annals of the American Thoracic Society|November 15, 2018
Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of IrelandLaura Kirwan, Godfrey Fletcher, Mary Harrington, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
NPJ Systems Biology and Applications|July 21, 2017
MUFINS: multi-formalism interaction network simulatorHuihai Wu, Axel von Kamp, Vytautas Leoncikas, et al.
Plos Biology|April 15, 2025
Monocyte-secreted Wnt reduces the efficiency of central nervous system remyelinationBianca M Hill, Rebecca K Holloway, Lindsey H Forbes, et al.
Pageof 34

Showing results (321-330 of 339) with videos related to

Sort By:
Pageof 34
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|October 1, 2018
Human epididymis protein 4 (HE4) levels inversely correlate with lung function improvement (delta FEV<sub>1</sub>) in cystic fibrosis patients receiving ivacaftor treatmentBéla Nagy, Zsolt Bene, Zsolt Fejes, et al.
Scientific Reports|November 6, 2025
Ultralow dose computed tomography as an alternative to conventional chest radiography for the evaluation of disease severity in paediatric cystic fibrosisMichael G Waldron, Patrick W O'Regan, Michael Lane, et al.
World Journal of Radiology|September 3, 2025
Ultra-low dose computed tomography chest <i>vs</i> chest radiography in paediatric primary ciliary dyskinesia: A prospective studyMichael G Waldron, Patrick W O'Regan, Michael Lane, et al.
The Journal of Infection|January 14, 2021
A multicentre analysis of Clostridium difficile in persons with Cystic Fibrosis demonstrates that carriage may be transient and highly variable with respect to strain and levelJennifer Deane, Fiona Fouhy, Nicola J Ronan, et al.
Scientific Reports|July 29, 2017
A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic FibrosisF Fouhy, N J Ronan, O O'Sullivan, et al.
Chest|October 18, 2017
CORK Study in Cystic Fibrosis: Sustained Improvements in Ultra-Low-Dose Chest CT Scores After CFTR Modulation With IvacaftorNicola J Ronan, Gisli G Einarsson, Maria Twomey, et al.
Annals of the American Thoracic Society|November 15, 2018
Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of IrelandLaura Kirwan, Godfrey Fletcher, Mary Harrington, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
NPJ Systems Biology and Applications|July 21, 2017
MUFINS: multi-formalism interaction network simulatorHuihai Wu, Axel von Kamp, Vytautas Leoncikas, et al.
Plos Biology|April 15, 2025
Monocyte-secreted Wnt reduces the efficiency of central nervous system remyelinationBianca M Hill, Rebecca K Holloway, Lindsey H Forbes, et al.
Pageof 34